| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Chemical Carcinogenesis, American Health Foundation, Valhalla, New York 10595
Metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent pulmonary carcinogen, have been quantified in the urine of 11 smokers. They were not detected in nonsmokers' urine. The metabolites, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronide, were detected in quantities of 0.231.0 and 0.576.5 µg/24 h, respectively. The results of this study provide the first evidence for metabolites of tobacco-specific nitrosamines in human urine.
1 This study was supported by Grant CA-29580 from the National Cancer Institute.
Received 11/17/92. Accepted 12/31/92.
This article has been cited by other articles:
![]() |
G. Chen, R. W. Dellinger, D. Sun, T. E. Spratt, and P. Lazarus Glucuronidation of Tobacco-Specific Nitrosamines by UGT2B10 Drug Metab. Dispos., May 1, 2008; 36(5): 824 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht, S. G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D. K. Hatsukami Metabolism of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone to Its Biomarker Total NNAL in Smokeless Tobacco Users Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 732 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Leslie, G. Ghibellini, K.-i. Nezasa, and K. L.R. Brouwer Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats Carcinogenesis, December 1, 2007; 28(12): 2650 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Stark, K. Rohde, J. E. Maher, B. A. Pizacani, C. W. Dent, R. Bard, S. G. Carmella, A. R. Benoit, N. M. Thomson, and S. S. Hecht The Impact of Clean Indoor Air Exemptions and Preemption Policies on the Prevalence of a Tobacco-Specific Lung Carcinogen Among Nonsmoking Bar and Restaurant Workers Am J Public Health, August 1, 2007; 97(8): 1457 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Melikian, M. V. Djordjevic, S. Chen, J. Richie Jr., and S. D. Stellman Effect of Delivered Dosage of Cigarette Smoke Toxins on the Levels of Urinary Biomarkers of Exposure Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1408 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Gallagher, J. E. Muscat, A. N. Hicks, Y. Zheng, A.-M. Dyer, G. A. Chase, J. Richie, and P. Lazarus The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 823 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Tobacco Carcinogen Biomarkers: Old and New Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 85 - 88. [Full Text] [PDF] |
||||
![]() |
D. Wiener, J.-L. Fang, N. Dossett, and P. Lazarus Correlation between UDP-Glucuronosyltransferase Genotypes and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Glucuronidation Phenotype in Human Liver Microsomes Cancer Res., February 1, 2004; 64(3): 1190 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wiener, D. R. Doerge, J.-L. Fang, P. Upadhyaya, and P. Lazarus CHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4 Drug Metab. Dispos., January 1, 2004; 32(1): 72 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Anderson, J. Kliris, L. Murphy, S. G. Carmella, S. Han, C. Link, R. L. Bliss, S. Puumala, S. E. Murphy, and S. S. Hecht Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Casino Patrons Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1544 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Shields Tobacco Smoking, Harm Reduction, and Biomarkers J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Upadhyaya, C. L. Zimmerman, and S. S. Hecht Metabolism and Pharmacokinetics of N'-Nitrosonornicotine in the Patas Monkey Drug Metab. Dispos., October 1, 2002; 30(10): 1115 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis, June 1, 2002; 23(6): 907 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wu, P. Upadhyaya, S. G. Carmella, S. S. Hecht, and C. L. Zimmerman Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution Carcinogenesis, January 1, 2002; 23(1): 171 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Anderson, S. G. Carmella, M. Ye, R. L. Bliss, C. Le, L. Murphy, and S. S. Hecht Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Women Exposed to Environmental Tobacco Smoke J Natl Cancer Inst, March 7, 2001; 93(5): 378 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9 Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360. [Abstract] [Full Text] |
||||
![]() |
P. Upadhyaya, S. G. Carmella, F.P. Guengerich, and S. S. Hecht Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues Carcinogenesis, June 1, 2000; 21(6): 1233 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ren, S. E. Murphy, A. J. Dannenberg, J. Y. Park, T. R. Tephly, and P. Lazarus Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by Rat UDP-Glucuronosyltransferase 2B1 Drug Metab. Dispos., September 1, 1999; 27(9): 1010 - 1016. [Abstract] [Full Text] |
||||
![]() |
G. B.J. Smith, A. Castonguay, P. J. Donnelly, K. R. Reid, D. Petsikas, and T. E. Massey Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells Carcinogenesis, September 1, 1999; 20(9): 1809 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Upadhyaya, P. M.J. Kenney, J. B. Hochalter, M. Wang, and S. S. Hecht Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse Carcinogenesis, August 1, 1999; 20(8): 1577 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Hecht Tobacco Smoke Carcinogens and Lung Cancer J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Meger, E. Richter, W. Zwickenpflug, C. Oehlmann, M. B. Hargaden, Y. I. A-Rahim, and E. S. Vesell Metabolism and Disposition of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK) in Rhesus Monkeys Drug Metab. Dispos., April 1, 1999; 27(4): 471 - 478. [Abstract] [Full Text] |
||||
![]() |
G. M. Lackmann, U. Salzberger, U. Tollner, M. Chen, S. G. Carmella, and S. S. Hecht Metabolites of a Tobacco-Specific Carcinogen in Urine From Newborns J Natl Cancer Inst, March 3, 1999; 91(5): 459 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Winn, P. M. Kim, and P. G. Wells Investigation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone for In Vivo and In Vitro Murine Embryopathy and Embryonic ras Mutations J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1128 - 1135. [Abstract] [Full Text] |
||||
![]() |
S. S. Hecht, S. G. Carmella, S. E. Murphy, S. Akerkar, K. D. Brunnemann, and D. Hoffmann A Tobacco-Specific Lung Carcinogen in the Urine of Men Exposed to Cigarette Smoke N. Engl. J. Med., November 18, 1993; 329(21): 1543 - 1546. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |